We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Merck has unveiled its plans to invest more than €440m to expand its membrane and filtration manufacturing capabilities in Ireland. The company will expand membrane manufacturing capacity at
Sanofi and Regeneron have obtained the US Food and Drug Administration (FDA) approval for Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children aged 12 years and above,
Chinese pharmaceutical firm Fosun Pharma, through its US subsidiary Fosun Pharma USA, has signed an exclusive license and option agreement with US-based VerImmune. VerImmune is engaged in developing
Biocon Biologics, a subsidiary of Indian biopharmaceutical firm Biocon, together with its partner Viatris, has announced the commercialisation of Abevmy (bBevacizumab) in Canada. Abevmy is a biosimilar to
Boehringer Ingelheim has received India’s Central Drugs Standard Control Organisation (CDSCO) approval to market Jardiance (empagliflozin) in the country. The drug is indicated for the treatment of people
Moderna, in partnership with International AIDS Vaccine Initiative (IAVI), is set to commence a Phase 1 clinical trial of an mRNA HIV vaccine antigen (mRNA-1644). IAVI is a
The Massachusetts Department of Public Health (DPH) announced that a confirmed case of monkeypox virus infection has been identified in a man who had recently travelled to Canada.
The US Food and Drug Administration (FDA) has expanded the emergency use authorisation (EUA) for a booster dose of Pfizer and BioNTech’s Covid-19 vaccine, to include children aged
AstraZeneca has entered into a licence agreement with the UK start-up RQ Biotechnology (RQ Bio), for its early-stage monoclonal antibodies (mAbs) against the SARS-CoV-2 virus. RQ Bio is
Abbott has signed a consent decree with the US Food and Drug Administration (FDA) to restart the production of infant formula at its facility in Sturgis, Michigan. The